Compression Device

DEVICE3 trials

Sponsors

ConvaTec Inc., Centre Hospitalier Universitaire de Besancon

Conditions

Healthy VolunteersKeloidLeg Ulcers

Phase 1

A Pressure Relted Study Comparing a Compression Device and Profore® on Healthy Volunteers

CompletedNCT00821808

ConvaTec Inc.Healthy Volunteers

Start: 2008-05-31End: 2008-06-30Updated: 2015-10-14

Phase 2

Compression Device Versus 4-layer Compression System

CompletedNCT00821431

ConvaTec Inc.Leg Ulcers

Start: 2006-05-31End: 2008-06-30Updated: 2015-01-09

Unknown Phase

Compressive Device to Prevent Keloïd Scars Recurrence [SCARWARS]

CompletedNCT03312166

Centre Hospitalier Universitaire de BesanconKeloid

Start: 2017-10-03End: 2023-12-14Updated: 2024-09-19

Related Papers

Halofuginone regulates keloid fibroblast fibrotic response to TGF-β induction.

2021-02-0124 citations